CID 3044582

Piperazine, 1-(10,11-dihydro-2-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methyl-, (z)-2-butenedioate (1:2)

Structural Information

Molecular Formula
C20H24N2S2
SMILES
CN1CCN(CC1)C2CC3=C(C=CC(=C3)SC)SC4=CC=CC=C24
InChI
InChI=1S/C20H24N2S2/c1-21-9-11-22(12-10-21)18-14-15-13-16(23-2)7-8-19(15)24-20-6-4-3-5-17(18)20/h3-8,13,18H,9-12,14H2,1-2H3
InChIKey
OKRSWVRGKPFTBH-UHFFFAOYSA-N
Compound name
1-methyl-4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)piperazine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

356.1381 Da
Monoisotopic Mass

4.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 357.145376 183.0
[M+Na]+ 379.127318 188.0
[M-H]- 355.130824 187.7
[M+NH4]+ 374.171923 195.1
[M+K]+ 395.101258 185.2
[M+H-H2O]+ 339.135360 175.4
[M+HCOO]- 401.136301 186.6
[M+CH3COO]- 415.151951 190.4
[M+Na-2H]- 377.112766 182.5
[M]+ 356.13755142 178.7
[M]- 356.13864858 178.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.